Stroke :: Lowering blood pressure following stroke may reduce damage
A new University of Georgia study suggests that commonly prescribed drugs used to lower blood pressure may help reduce brain damage when given within 24 hours of a stroke.
A new University of Georgia study suggests that commonly prescribed drugs used to lower blood pressure may help reduce brain damage when given within 24 hours of a stroke.
Whiskers provide a mouse with essential information to negotiate a burrow or detect movement that could signal a predator’s presence. These stiff hairs relay sensory input to the brain, which shapes neuronal activity.
This is the impressive result of a study carried out by a group of researchers coordinated by Dr. Maria Grazia De Simoni of the Mario Negri Institute in Milan, Italy, in cooperation with the Istituto Neurologico Besta (Milan) and the University of Lausanne. The study is to be published in the April 18 issue of the international, peer-reviewed, open-access online journal of the Public Library of Science, PLoS ONE.
Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
CNRS scientists in France, in collaboration with Canadian scientists, have identified the key structure for the memory formation of social information.
Potential drug interactions from prescribed medications are common among cancer patients and may cause unnecessary harm, according to a study in the April 18 Journal of the National Cancer Institute.
A type of omega-3 fatty acid may slow the growth of two brain lesions that are hallmarks of Alzheimer’s disease, UC Irvine scientists have discovered. The finding suggests that diets rich in docosahexaenoic acid (DHA) can help prevent the development of Alzheimer’s disease later in life.
According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI?) ? a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) ? also reduces vision loss in patients with relapsing MS.
CNRS scientists in collaboration have developed a new technique for the in vivo imaging of neuronal function using bioluminescence, based on a GFP-aequorin fusion protein.
A team of 19 researchers from Australia, Canada, Iceland, Singapore, and several European countries has completed what they call the “largest population-based study of absolute and relative risk of second malignant neoplasms (SMNs)” in childhood leukemia and lymphoma survivors.